As of January 27, 2025, Co-Diagnostics (CODX) has a market cap of $25.576 million USD. According to our data, Co-Diagnostics is ranked No.8504 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 27, 2025 | $25.58 M |
6.80%
|
Dec 31, 2024 | $23.95 M |
-43.61%
|
Dec 29, 2023 | $42.47 M |
-47.22%
|
Dec 30, 2022 | $80.46 M |
-71.78%
|
Dec 31, 2021 | $0.29 B |
-3.98%
|
Dec 31, 2020 | $0.30 B |
939.11%
|
Dec 31, 2019 | $28.58 M |
-39.93%
|
Dec 31, 2018 | $47.58 M |
-43.56%
|
Dec 29, 2017 | $84.29 M |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Thermo Fisher Scientific
TMO
|
$221.42 B |
-0.002 M
|
USA
|
Bio-Rad Laboratories
BIO
|
$10.01 B |
1.873 B
|
USA
|
Qiagen
QGEN
|
$10.21 B |
68.899 M
|
Netherlands
|
Hologic
HOLX
|
$16.38 B |
0.350 B
|
USA
|
Illumina
ILMN
|
$21.57 B |
-0.035 B
|
USA
|
Agilent Technologies
A
|
$42.90 B |
0.000 M
|
USA
|
Becton Dickinson
BDX
|
$71.35 B |
0.748 B
|
USA
|
Danaher
DHR
|
$179.13 B |
-0.004 M
|
USA
|
Abbott Laboratories
ABT
|
$223.03 B |
0.007 M
|
USA
|
QuidelOrtho
QDEL
|
$3.03 B |
51.115 M
|
USA
|
Market Cap | = | CODX Stock Price | * | CODX Shares Outstanding |
= | $0.80 | * | 31.93 M | |
= | $25.58 M |